These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 540347)

  • 21. Chemotherapeutic trials in psychosis. III. Addendum-2-brom-d-lysergic acid diethylamide (BOL).
    TURNER WJ; ALMUDEVAR M; MERLIS S
    Am J Psychiatry; 1959 Sep; 116():261-2. PubMed ID: 13839967
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 23. Some pharmacological actions of D-lysergic acid methyl carbinolamide.
    GLASSER A
    Nature; 1961 Jan; 189():313-4. PubMed ID: 13705953
    [No Abstract]   [Full Text] [Related]  

  • 24. Oxytocic effect of some d-lysergic acid cycloalkylamides.
    VOTAVA Z; PODVALOVA I; SEMONSKY M
    Nature; 1957 Mar; 179(4557):474-5. PubMed ID: 13407748
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypothesis concerning the biosynthesis of lysergic acid.
    FELDSTEIN A
    Experientia; 1956 Dec; 12(12):475-6. PubMed ID: 13397535
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapeutic trials in psychosis. III. 2-Brom-d-lysergic acid diethylamide (BOL 148).
    TURNER WJ; MERLIS S
    Am J Psychiatry; 1958 Feb; 114(8):751-2. PubMed ID: 13498199
    [No Abstract]   [Full Text] [Related]  

  • 27. The synthesis of substituted arylalkylaminopropionamide analogues of lysergic acid diethylamide and their effect upon isolated cholinesterase systems.
    LASSLO A; WALLER PD; MEYER AL; SASTRY BV
    J Med Pharm Chem; 1960 Dec; 2():617-31. PubMed ID: 13759325
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemical structure and lysergic acid derivative psychoses].
    SOLMS H
    Praxis; 1956 Aug; 45(32):746-9. PubMed ID: 13359249
    [No Abstract]   [Full Text] [Related]  

  • 29. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Butanolamide of 1-methyl-D-lysergic acid and histamine liberation].
    LECOMTE J; LAPIERE CM
    C R Seances Soc Biol Fil; 1960; 154():2386-9. PubMed ID: 13760117
    [No Abstract]   [Full Text] [Related]  

  • 31. Experimental studies with the butanolamide and propanolamide of 1-methyl-lysergic acid.
    GELFAND MD; WEST GB
    Int Arch Allergy Appl Immunol; 1961; 18():286-91. PubMed ID: 13704268
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes.
    Klette KL; Anderson CJ; Poch GK; Nimrod AC; ElSohly MA
    J Anal Toxicol; 2000 Oct; 24(7):550-6. PubMed ID: 11043658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A central nervous system effect of a nonhallucinatory lysergic acid derivative.
    SPIRTES MA; GUTH PS; POLLEY EH
    Experientia; 1958 Nov; 14(11):428. PubMed ID: 13609622
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 35. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Research on the problem of schizophrenia using radiocarbon-labeled lysergic acid diethylamide & succinic acid].
    ARNOLD OH; HOFMANN G; LEUPOLDLOWENTHAL H
    Strahlentherapie; 1958; 107(Sonderbd. 38):59-65; discussion 66-7. PubMed ID: 13603137
    [No Abstract]   [Full Text] [Related]  

  • 37. [Probable existence of D-lysergic acid diethylamide in infections caused by Toxoplasma gondii].
    VARELA G; VAZQUEZ A; TORROELLA J
    Rev Inst Salubr Enferm Trop; 1956 Dec; 16(4):29-32. PubMed ID: 13453992
    [No Abstract]   [Full Text] [Related]  

  • 38. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.
    SICUTERI F
    Int Arch Allergy Appl Immunol; 1959; 15():300-7. PubMed ID: 14446408
    [No Abstract]   [Full Text] [Related]  

  • 39. Lysergic acid diethylamide (LSD-25). XXXI. Comparison by questionnaire of psychotomimetic activity of congeners on normal subjects and drug addicts.
    ABRAMSON HA
    J Ment Sci; 1960 Jul; 106():1120-3. PubMed ID: 13681136
    [No Abstract]   [Full Text] [Related]  

  • 40. [Psychopathological experiences with the combined action of lysergic acid mono- & diethylamide (LAE-32, LSD-25)].
    CALLIERI B; RAVETTA M
    Riv Sper Freniatr Med Leg Alien Ment; 1957 Jul; 81(2):267-313. PubMed ID: 13466954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.